Defining central themes in breast cancer biology by differential proteomics: Conserved regulation of cell spreading and focal adhesion kinase

Journal of Proteome Research

Volumn 9, Issue 10, 2010, Pages 5311-5324

  Bateman, Nicholas W ^a   Sun, Mai ^a   Hood, Brian L ^a   Flint, Melanie S ^a   Conrads, Thomas P ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

breast cancer; cell spreading; focal adhesion kinase; mass spectrometry; proteomics

Indexed keywords

CYTOKERATIN 19; FOCAL ADHESION KINASE; MEMBRANE METALLOENDOPEPTIDASE;

ARTICLE; BREAST CANCER; BREAST CELL; CELL MEMBRANE; CELL NUCLEUS; CELL SPREADING; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEOMICS;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CHROMATOGRAPHY, LIQUID; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MAMMARY GLANDS, HUMAN; MEMBRANE PROTEINS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 77957329708     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr100580e     Document Type: Article

References (100)

1. Hahn, W. C.; Weinberg, R. A. Modelling the molecular circuitry of cancer Nat. Rev. Cancer 2002, 2 (5) 331-41
2. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer Cell 2000, 100 (1) 57-70
3. Dimri, G.; Band, H.; Band, V. Mammary epithelial cell transformation: insights from cell culture and mouse models Breast Cancer Res. 2005, 7 (4) 171-9
4. Kenemans, P.; Verstraeten, R. A.; Verheijen, R. H. Oncogenic pathways in hereditary and sporadic breast cancer Maturitas 2004, 49 (1) 34-43
5. Souchelnytskyi, S. Proteomics in studies of signal transduction in epithelial cells J. Mammary Gland Biol. Neoplasia 2002, 7 (4) 359-71
6. Charafe-Jauffret, E.; Ginestier, C.; Monville, F.; Finetti, P.; Adelaide, J.; Cervera, N.; Fekairi, S.; Xerri, L.; Jacquemier, J.; Birnbaum, D.; Bertucci, F. Gene expression profiling of breast cell lines identifies potential new basal markers Oncogene 2006, 25 (15) 2273-84
7. Fu, J.; Jeffrey, S. S. Transcriptomic signatures in breast cancer Mol. Biosyst. 2007, 3 (7) 466-72
8. Neve, R. M.; Chin, K.; Fridlyand, J.; Yeh, J.; Baehner, F. L.; Fevr, T.; Clark, L.; Bayani, N.; Coppe, J. P.; Tong, F.; Speed, T.; Spellman, P. T.; DeVries, S.; Lapuk, A.; Wang, N. J.; Kuo, W. L.; Stilwell, J. L.; Pinkel, D.; Albertson, D. G.; Waldman, F. M.; McCormick, F.; Dickson, R. B.; Johnson, M. D.; Lippman, M.; Ethier, S.; Gazdar, A.; Gray, J. W. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 2006, 10 (6) 515-27
9. Shipitsin, M.; Campbell, L. L.; Argani, P.; Weremowicz, S.; Bloushtain-Qimron, N.; Yao, J.; Nikolskaya, T.; Serebryiskaya, T.; Beroukhim, R.; Hu, M.; Halushka, M. K.; Sukumar, S.; Parker, L. M.; Anderson, K. S.; Harris, L. N.; Garber, J. E.; Richardson, A. L.; Schnitt, S. J.; Nikolsky, Y.; Gelman, R. S.; Polyak, K. Molecular definition of breast tumor heterogeneity Cancer Cell 2007, 11 (3) 259-73
10. Bhargava, R.; Beriwal, S.; Dabbs, D. J.; Ozbek, U.; Soran, A.; Johnson, R. R.; Brufsky, A. M.; Lembersky, B. C.; Ahrendt, G. M. Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy: a single institutional experience with 359 cases Cancer 2010, 116 (6) 1431-9
11. Perou, C. M.; Sorlie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S.; Rees, C. A.; Pollack, J. R.; Ross, D. T.; Johnsen, H.; Akslen, L. A.; Fluge, O.; Pergamenschikov, A.; Williams, C.; Zhu, S. X.; Lonning, P. E.; Borresen-Dale, A. L.; Brown, P. O.; Botstein, D. Molecular portraits of human breast tumours Nature 2000, 406 (6797) 747-52
12. Sims, A. H.; Howell, A.; Howell, S. J.; Clarke, R. B. Origins of breast cancer subtypes and therapeutic implications Nat. Clin. Pract. Oncol. 2007, 4 (9) 516-25
13. Sorlie, T.; Perou, C. M.; Tibshirani, R.; Aas, T.; Geisler, S.; Johnsen, H.; Hastie, T.; Eisen, M. B.; van de Rijn, M.; Jeffrey, S. S.; Thorsen, T.; Quist, H.; Matese, J. C.; Brown, P. O.; Botstein, D.; Eystein Lonning, P.; Borresen-Dale, A. L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc. Natl. Acad. Sci. U.S.A. 2001, 98 (19) 10869-74
14. Hondermarck, H.; Dolle, L.; El Yazidi-Belkoura, I.; Vercoutter-Edouart, A. S.; Adriaenssens, E.; Lemoine, J. Functional proteomics of breast cancer for signal pathway profiling and target discovery J. Mammary Gland Biol. Neoplasia 2002, 7 (4) 395-405
15. Chuang, H. Y.; Lee, E.; Liu, Y. T.; Lee, D.; Ideker, T. Network-based classification of breast cancer metastasis Mol. Syst. Biol. 2007, 3, 140
16. Gatza, M. L.; Lucas, J. E.; Barry, W. T.; Kim, J. W.; Wang, Q.; Crawford, M. D.; Datto, M. B.; Kelley, M.; Mathey-Prevot, B.; Potti, A.; Nevins, J. R. A pathway-based classification of human breast cancer Proc. Natl. Acad. Sci. U.S.A. 2010, 107 (15) 6994-9
17. Adam, P. J.; Boyd, R.; Tyson, K. L.; Fletcher, G. C.; Stamps, A.; Hudson, L.; Poyser, H. R.; Redpath, N.; Griffiths, M.; Steers, G.; Harris, A. L.; Patel, S.; Berry, J.; Loader, J. A.; Townsend, R. R.; Daviet, L.; Legrain, P.; Parekh, R.; Terrett, J. A. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer J. Biol. Chem. 2003, 278 (8) 6482-9
18. Imai, K.; Ichibangase, T.; Saitoh, R.; Hoshikawa, Y. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry Biomed. Chromatogr. 2008, 22 (11) 1304-14
19. Kulasingam, V.; Diamandis, E. P. Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets Mol. Cell. Proteomics 2007, 6 (11) 1997-2011
20. Lai, T. C.; Chou, H. C.; Chen, Y. W.; Lee, T. R.; Chan, H. T.; Shen, H. H.; Lee, W. T.; Lin, S. T.; Lu, Y. C.; Wu, C. L.; Chan, H. L. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis J. Proteome Res. 2010, 9 (3) 1302-22
21. 18O-labeling and an accurate mass and time tag strategy Proteomics 2006, 6 (9) 2903-15
22. Smith, L.; Welham, K. J.; Watson, M. B.; Drew, P. J.; Lind, M. J.; Cawkwell, L. The proteomic analysis of cisplatin resistance in breast cancer cells Oncol. Res. 2007, 16 (11) 497-506
23. Wu, S. L.; Hancock, W. S.; Goodrich, G. G.; Kunitake, S. T. An approach to the proteomic analysis of a breast cancer cell line (SKBR-3) Proteomics 2003, 3 (6) 1037-46
24. Hathout, Y.; Gehrmann, M. L.; Chertov, A.; Fenselau, C. Proteomic phenotyping: metastatic and invasive breast cancer Cancer Lett. 2004, 210 (2) 245-53
25. Patwardhan, A. J.; Strittmatter, E. F.; Camp, D. G., 2nd; Smith, R. D.; Pallavicini, M. G. Comparison of normal and breast cancer cell lines using proteome, genome, and interactome data J. Proteome Res. 2005, 4 (6) 1952-60
26. Engel, L. W.; Young, N. A. Human breast carcinoma cells in continuous culture: a review Cancer Res. 1978, 38 (11 Pt 2) 4327-39
27. Lacroix, M.; Leclercq, G. Relevance of breast cancer cell lines as models for breast tumours: an update Breast Cancer Res. Treat. 2004, 83 (3) 249-89
28. Seibert, K.; Shafie, S. M.; Triche, T. J.; Whang-Peng, J. J.; OBrien, S. J.; Toney, J. H.; Huff, K. K.; Lippman, M. E. Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice Cancer Res. 1983, 43 (5) 2223-39
29. Fogh, J.; Fogh, J. M.; Orfeo, T. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice J. Natl. Cancer Inst. 1977, 59 (1) 221-6
30. Soule, H. D.; Maloney, T. M.; Wolman, S. R.; Peterson, W. D., Jr.; Brenz, R.; McGrath, C. M.; Russo, J.; Pauley, R. J.; Jones, R. F.; Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10 Cancer Res. 1990, 50 (18) 6075-86 (Pubitemid 20331424)
31. Bissell, M. J.; Radisky, D. Putting tumours in context Nat. Rev. Cancer 2001, 1 (1) 46-54
32. Ghajar, C. M.; Bissell, M. J. Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging Histochem. Cell Biol. 2008, 130 (6) 1105-18
33. Konety, B. R.; Getzenberg, R. H. Nuclear structural proteins as biomarkers of cancer J. Cell Biochem. 1999, 32-33, 183-91
34. Luo, M.; Guan, J. L. Focal adhesion kinase: a prominent determinant in breast cancer initiation, progression and metastasis Cancer Lett. 2010, 289 (2) 127-39
35. Elias, J. E.; Gygi, S. P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry Nat. Methods 2007, 4 (3) 207-14
36. Marengo, E.; Robotti, E.; Bobba, M.; Gosetti, F. The principle of exhaustiveness versus the principle of parsimony: a new approach for the identification of biomarkers from proteomic spot volume datasets based on principal component analysis Anal. Bioanal. Chem. 2010, 397 (1) 25-41
37. Ferguson, R. E.; Carroll, H. P.; Harris, A.; Maher, E. R.; Selby, P. J.; Banks, R. E. Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies Proteomics 2005, 5 (2) 566-71
38. McDonald, J. H. Data Transformations. Handbook of Biological Statistics; Sparky House Publishing: Baltimore, MD, 2009; pp 160 - 164.
39. Sommers, C. L.; Byers, S. W.; Thompson, E. W.; Torri, J. A.; Gelmann, E. P. Differentiation state and invasiveness of human breast cancer cell lines Breast Cancer Res. Treat. 1994, 31 (2-3) 325-35
40. Kass, L.; Erler, J. T.; Dembo, M.; Weaver, V. M. Mammary epithelial cell: influence of extracellular matrix composition and organization during development and tumorigenesis Int. J. Biochem. Cell Biol. 2007, 39 (11) 1987-94
41. Cuvelier, D.; Thery, M.; Chu, Y. S.; Dufour, S.; Thiery, J. P.; Bornens, M.; Nassoy, P.; Mahadevan, L. The universal dynamics of cell spreading Curr. Biol. 2007, 17 (8) 694-9
42. Gilcrease, M. Z. Integrin signaling in epithelial cells Cancer Lett. 2007, 247 (1) 1-25
43. Streuli, C. H.; Gilmore, A. P. Adhesion-mediated signaling in the regulation of mammary epithelial cell survival J. Mammary Gland Biol. Neoplasia 1999, 4 (2) 183-91
44. Goldfinger, L. E.; Stack, M. S.; Jones, J. C. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator J. Cell Biol. 1998, 141 (1) 255-65
45. Stahl, S.; Weitzman, S.; Jones, J. C. The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis J. Cell Sci. 1997, 110 (1) 55-63
46. Martin, S. S.; Leder, P. Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2 Mol. Cell. Biol. 2001, 21 (19) 6529-36
47. Tait, L.; Soule, H. D.; Russo, J. Ultrastructural and immunocytochemical characterization of an immortalized human breast epithelial cell line, MCF-10 Cancer Res. 1990, 50 (18) 6087-94 (Pubitemid 20331425)
48. Wang, H. B.; Dembo, M.; Wang, Y. L. Substrate flexibility regulates growth and apoptosis of normal but not transformed cells Am. J. Physiol. Cell Physiol. 2000, 279 (5) C1345-50
49. Bambang, I. F.; Lu, D.; Li, H.; Chiu, L. L.; Lau, Q. C.; Koay, E.; Zhang, D. Cytokeratin 19 regulates endoplasmic reticulum stress and inhibits ERp29 expression via p38 MAPK/XBP-1 signaling in breast cancer cells Exp. Cell Res. 2009, 315 (11) 1964-74
50. Nerlich, A. G.; Lebeau, A.; Hagedorn, H. G.; Sauer, U.; Schleicher, E. D. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx Anticancer Res. 1998, 18 (5A) 3515-20
51. Prince, J. M.; Klinowska, T. C.; Marshman, E.; Lowe, E. T.; Mayer, U.; Miner, J.; Aberdam, D.; Vestweber, D.; Gusterson, B.; Streuli, C. H. Cell-matrix interactions during development and apoptosis of the mouse mammary gland in vivo Dev. Dyn. 2002, 223 (4) 497-516
52. Valladares, A.; Hernandez, N. G.; Gomez, F. S.; Curiel-Quezada, E.; Madrigal-Bujaidar, E.; Vergara, M. D.; Martinez, M. S.; Arenas Aranda, D. J. Genetic expression profiles and chromosomal alterations in sporadic breast cancer in Mexican women Cancer Genet. Cytogenet. 2006, 170 (2) 147-51
53. Colorado, P. C.; Torre, A.; Kamphaus, G.; Maeshima, Y.; Hopfer, H.; Takahashi, K.; Volk, R.; Zamborsky, E. D.; Herman, S.; Sarkar, P. K.; Ericksen, M. B.; Dhanabal, M.; Simons, M.; Post, M.; Kufe, D. W.; Weichselbaum, R. R.; Sukhatme, V. P.; Kalluri, R. Anti-angiogenic cues from vascular basement membrane collagen Cancer Res. 2000, 60 (9) 2520-6
54. Long, M. Y.; Li, H. H.; Xu, J. Y.; Lai, D. M.; Weng, Z. H. [Inhibitory effects of transfection of arresten gene on liver metastasis from colorectal cancer in nude mice] Ai Zheng 2008, 27 (10) 1039-43
55. Tandle, A.; Blazer, D. G., 3rd; Libutti, S. K. Antiangiogenic gene therapy of cancer: recent developments J. Transl. Med. 2004, 2 (1) 22
56. Kamphaus, G. D.; Colorado, P. C.; Panka, D. J.; Hopfer, H.; Ramchandran, R.; Torre, A.; Maeshima, Y.; Mier, J. W.; Sukhatme, V. P.; Kalluri, R. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth J. Biol. Chem. 2000, 275 (2) 1209-15
57. Bax, D. V.; Mahalingam, Y.; Cain, S.; Mellody, K.; Freeman, L.; Younger, K.; Shuttleworth, C. A.; Humphries, M. J.; Couchman, J. R.; Kielty, C. M. Cell adhesion to fibrillin-1: identification of an Arg-Gly-Asp-dependent synergy region and a heparin-binding site that regulates focal adhesion formation J. Cell Sci. 2007, 120 (Pt 8) 1383-92
58. Golden, H. B.; Watson, L. E.; Lal, H.; Verma, S. K.; Foster, D. M.; Kuo, S. R.; Sharma, A.; Frankel, A.; Dostal, D. E. Anthrax toxin: pathologic effects on the cardiovascular system Front. Biosci. 2009, 14, 2335-57
59. Hauzenberger, D.; Olivier, P.; Gundersen, D.; Ruegg, C. Tenascin-C inhibits beta1 integrin-dependent T lymphocyte adhesion to fibronectin through the binding of its fnIII 1-5 repeats to fibronectin Eur. J. Immunol. 1999, 29 (5) 1435-47
60. Horiuchi, K.; Amizuka, N.; Takeshita, S.; Takamatsu, H.; Katsuura, M.; Ozawa, H.; Toyama, Y.; Bonewald, L. F.; Kudo, A. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta J. Bone Miner. Res. 1999, 14 (7) 1239-49
61. Jin, L.; Kern, M. J.; Otey, C. A.; Wamhoff, B. R.; Somlyo, A. V.; Angiotensin, I. I. focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration Circ. Res. 2007, 100 (6) 817-25
62. Kim, J. E.; Kim, S. J.; Lee, B. H.; Park, R. W.; Kim, K. S.; Kim, I. S. Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3 J. Biol. Chem. 2000, 275 (40) 30907-15
63. Lange, K.; Kammerer, M.; Saupe, F.; Hegi, M. E.; Grotegut, S.; Fluri, E.; Orend, G. Combined lysophosphatidic acid/platelet-derived growth factor signaling triggers glioma cell migration in a tenascin-C microenvironment Cancer Res. 2008, 68 (17) 6942-52
64. Liu, X. S.; Luo, H. J.; Yang, H.; Wang, L.; Kong, H.; Jin, Y. E.; Wang, F.; Gu, M. M.; Chen, Z.; Lu, Z. Y.; Wang, Z. G. Palladin regulates cell and extracellular matrix interaction through maintaining normal actin cytoskeleton architecture and stabilizing beta1-integrin J. Cell. Biochem. 2007, 100 (5) 1288-300
65. Nishiya, N.; Tachibana, K.; Shibanuma, M.; Mashimo, J. I.; Nose, K. Hic-5-reduced cell spreading on fibronectin: competitive effects between paxillin and Hic-5 through interaction with focal adhesion kinase Mol. Cell. Biol. 2001, 21 (16) 5332-45
66. Popova, S. N.; Barczyk, M.; Tiger, C. F.; Beertsen, W.; Zigrino, P.; Aszodi, A.; Miosge, N.; Forsberg, E.; Gullberg, D. Alpha11 beta1 integrin-dependent regulation of periodontal ligament function in the erupting mouse incisor Mol. Cell. Biol. 2007, 27 (12) 4306-16
67. Prieto, A. L.; Edelman, G. M.; Crossin, K. L. Multiple integrins mediate cell attachment to cytotactin/tenascin Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (21) 10154-8
68. Summers, L.; Kielty, C.; Pinteaux, E. Adhesion to fibronectin regulates interleukin-1 beta expression in microglial cells Mol. Cell. Neurosci. 2009, 41 (2) 148-55
69. Werner, E.; Kowalczyk, A. P.; Faundez, V. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton J. Biol. Chem. 2006, 281 (32) 23227-36
70. Yayon, A.; Klagsbrun, M. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin Proc. Natl. Acad. Sci. U.S.A. 1990, 87 (14) 5346-50
71. Zagzag, D.; Shiff, B.; Jallo, G. I.; Greco, M. A.; Blanco, C.; Cohen, H.; Hukin, J.; Allen, J. C.; Friedlander, D. R. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase Cancer Res. 2002, 62 (9) 2660-8
72. Zhang, M.; Liu, J.; Cheng, A.; Deyoung, S. M.; Saltiel, A. R. Identification of CAP as a costameric protein that interacts with filamin C Mol. Biol. Cell 2007, 18 (12) 4731-40
73. Calaf, G. M.; Echiburu-Chau, C.; Zhao, Y. L.; Hei, T. K. BigH3 protein expression as a marker for breast cancer Int. J. Mol. Med. 2008, 21 (5) 561-8
74. Korah, R.; Das, K.; Lindy, M. E.; Hameed, M.; Wieder, R. Coordinate loss of fibroblast growth factor 2 and laminin 5 expression during neoplastic progression of mammary duct epithelium Hum. Pathol. 2007, 38 (1) 154-60
75. Murabito, J. M.; Rosenberg, C. L.; Finger, D.; Kreger, B. E.; Levy, D.; Splansky, G. L.; Antman, K.; Hwang, S. J. A genome-wide association study of breast and prostate cancer in the NHLBIs Framingham Heart Study BMC Med. Genet. 2007, 8 (1) S6
76. Davies, G.; Rmali, K. A.; Watkins, G.; Mansel, R. E.; Mason, M. D.; Jiang, W. G. Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance Int. J. Oncol. 2006, 29 (5) 1311-7
77. Ruan, K.; Bao, S.; Ouyang, G. The multifaceted role of periostin in tumorigenesis Cell. Mol. Life Sci. 2009, 66 (14) 2219-30
78. Zhang, Y.; Zhang, G.; Li, J.; Tao, Q.; Tang, W. The expression analysis of periostin in human breast cancer J. Surg. Res. 2010, 160 (1) 102-6
79. Heitzer, M. D.; DeFranco, D. B. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator Mol. Endocrinol. 2006, 20 (1) 56-64
80. Tumbarello, D. A.; Turner, C. E. Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway J. Cell Physiol. 2007, 211 (3) 736-47
81. Hancox, R. A.; Allen, M. D.; Holliday, D. L.; Edwards, D. R.; Pennington, C. J.; Guttery, D. S.; Shaw, J. A.; Walker, R. A.; Pringle, J. H.; Jones, J. L. Tumour-associated tenascin-C isoforms promote breast cancer cell invasion and growth by matrix metalloproteinase-dependent and independent mechanisms Breast Cancer Res. 2009, 11 (2) R24
82. Midwood, K. S.; Orend, G. The role of tenascin-C in tissue injury and tumorigenesis J. Cell Commun. Signal. 2009, 3, 287-310
83. Flaxman, B. A.; Van Scott, E. J. Growth of normal human mammary gland epithelium in vitro Cancer Res. 1972, 32 (11) 2407-12
84. Kaneda, A.; Kaminishi, M.; Yanagihara, K.; Sugimura, T.; Ushijima, T. Identification of silencing of nine genes in human gastric cancers Cancer Res. 2002, 62 (22) 6645-50
85. Pogue-Geile, K. L.; Chen, R.; Bronner, M. P.; Crnogorac-Jurcevic, T.; Moyes, K. W.; Dowen, S.; Otey, C. A.; Crispin, D. A.; George, R. D.; Whitcomb, D. C.; Brentnall, T. A. Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism PLoS Med. 2006, 3 (12 e516
86. Pirone, D. M.; Liu, W. F.; Ruiz, S. A.; Gao, L.; Raghavan, S.; Lemmon, C. A.; Romer, L. H.; Chen, C. S. An inhibitory role for FAK in regulating proliferation: a link between limited adhesion and RhoA-ROCK signaling J. Cell Biol. 2006, 174 (2) 277-88
87. Lahlou, H.; Sanguin-Gendreau, V.; Zuo, D.; Cardiff, R. D.; McLean, G. W.; Frame, M. C.; Muller, W. J. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (51) 20302-7
88. Wendt, M. K.; Schiemann, W. P. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis Breast Cancer Res. 2009, 11 (5) R68
89. Streuli, C. H.; Edwards, G. M. Control of normal mammary epithelial phenotype by integrins J. Mammary Gland Biol. Neoplasia 1998, 3 (2) 151-63
90. Boudreau, N. J.; Jones, P. L. Extracellular matrix and integrin signalling: the shape of things to come Biochem. J. 1999, 339 (3) 481-8
91. Pylayeva, Y.; Gillen, K. M.; Gerald, W.; Beggs, H. E.; Reichardt, L. F.; Giancotti, F. G. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling J. Clin. Invest. 2009, 119 (2) 252-66
92. Kobayashi, H.; Azumi, M.; Kimura, Y.; Sato, K.; Aoki, N.; Kimura, S.; Honma, M.; Iizuka, H.; Tateno, M.; Celis, E. Focal adhesion kinase as an immunotherapeutic target Cancer Immunol. Immunother. 2009, 58 (6) 931-40
93. Sawhney, R. S.; Liu, W.; Brattain, M. G. A novel role of ERK5 in integrin-mediated cell adhesion and motility in cancer cells via Fak signaling J. Cell Physiol. 2009, 219 (1) 152-61
94. Panka, D. J.; Mier, J. W. Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells J. Biol. Chem. 2003, 278 (39) 37632-6
95. Sumitomo, M.; Shen, R.; Walburg, M.; Dai, J.; Geng, Y.; Navarro, D.; Boileau, G.; Papandreou, C. N.; Giancotti, F. G.; Knudsen, B.; Nanus, D. M. Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling J. Clin. Invest. 2000, 106 (11) 1399-407
96. Wu, Y.; Chen, L.; Zheng, P. S.; Yang, B. B. beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican J. Biol. Chem. 2002, 277 (14) 12294-301
97. Smollich, M.; Gotte, M.; Yip, G. W.; Yong, E. S.; Kersting, C.; Fischgrabe, J.; Radke, I.; Kiesel, L.; Wulfing, P. On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer Breast Cancer Res. Treat. 2007, 106 (3) 361-9
98. Iwaya, K.; Ogawa, H.; Izumi, M.; Kuroda, M.; Mukai, K. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome Virchows Arch. 2002, 440 (6) 589-93
99. Alix-Panabieres, C.; Vendrell, J. P.; Slijper, M.; Pelle, O.; Barbotte, E.; Mercier, G.; Jacot, W.; Fabbro, M.; Pantel, K. Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer Breast Cancer Res. 2009, 11 (3) R39
100. Suwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V. M.; LeBaron, R. G.; Raymond, W. A.; Tilley, W. D.; Horsfall, D. J. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer Clin. Cancer Res. 2004, 10 (7) 2491-8